Article Text

Download PDFPDF
Subcutaneous naltrexone implants reduce opioid use in opiate dependent patients

Statistics from


  • Sources of funding South Eastern Norway Health Authority and Aker University Hospital.


  • Competing interests None

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles